Gene Editing Genome Genome Project Marketing 
Drug Discovery World
OCTOBER 16, 2023
Maina Bhaman, Partner at Sofinnova Partners, says: “The UK is an attractive space for drug discovery companies and a prime environment for investment due to its talent, infrastructure, and genomics research. We also recently opened the Scientific Centre of Excellence for Genomic Insight at our Cambridge site.”
pharmaphorum
APRIL 20, 2022
The potential to develop treatments with CRISPR gene editing is hinged on its ability to add, delete or replace elements within a target DNA sequence. The potential for CRISPR gene editing to offer a therapeutic option to patients is clear, based on its mechanism, but there are already gene editing therapeutics on the market.
Expert insights. Personalized for you.
75 
Let's personalize your content